Figure legends
Figure 1. Comparison of COHb levels at admission and on day 5 of treatment in COVID-19 patients who did and did not develop macrophage activation syndrome (MAS) and acute respiratory distress syndrome (ARDS)
Figure 2. Correlation analysis of COHb level with CRP and PaO2/FiO2 levels in COVID-19 patients